NCT05724836 Prospective Carotid Artery Stenosis Trial
| NCT ID | NCT05724836 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Patients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery Plaque |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-04-12 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-04-12 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Researchers are collecting information and blood from subjects undergoing carotid artery interventions.
Eligibility Criteria
Inclusion Criteria: * All subjects undergoing carotid artery intervention that presents to our clinic Exclusion Criteria: * None
Contact & Investigator
Young M Erben
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05724836 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Patients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery Plaque. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05724836 currently recruiting?
Yes, NCT05724836 is actively recruiting participants. Visit ClinicalTrials.gov or contact Mayo Clinic to inquire about joining.
Where is the NCT05724836 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT05724836 clinical trial?
NCT05724836 is sponsored by Mayo Clinic. The principal investigator is Young M Erben at Mayo Clinic. The trial plans to enroll 200 participants.